Compounds > 2-hydroxy-1-4-benzoxazin-3-one

2-hydroxy-1-4-benzoxazin-3-one and Chemical-and-Drug-Induced-Liver-Injury

2-hydroxy-1-4-benzoxazin-3-one has been researched along with Chemical-and-Drug-Induced-Liver-Injury* in 1 studies

Other Studies

1 other study(ies) available for 2-hydroxy-1-4-benzoxazin-3-one and Chemical-and-Drug-Induced-Liver-Injury

Article	Year
4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice. International immunopharmacology, 2020, Volume: 83 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Benzoxazines; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Galactose; Hepatocytes; Humans; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Signal Transduction; Toll-Like Receptor 5	2020

Article

Year

4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice.

International immunopharmacology, 2020, Volume: 83

Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Benzoxazines; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Galactose; Hepatocytes; Humans; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Signal Transduction; Toll-Like Receptor 5

2020